revers decis posit sanofi/regeneron district court
district delawar today revers juri verdict uphold valid
patent repatha previous comment
judg found patent invalid base lack enabl
mean pend injunct moot assum
appeal decis feder circuit court see rel posit
regeneron said believ keep statu quo
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
valuat risk
price target base dcf model use discount rate
termin growth rate post flow base explicit revenu
project near-term revenu driver eylea wet retin
vein occlus dme dupix dupilumab atop dermat asthma
addit revenu driver praluent kevzara sarilumab dupix praluent
kevzara partner sanofi eylea partner bayer ex-u
partnership factor dcf risk includ unexpect flatten
dupix launch trajectori continu sluggish sale praluent competit
sasi pa cover mark purcel
methodolog sanofi equal-weight price target
pt deriv dcf product-by-product sale forecast
assum wacc termin growth revers roce cost
capit long term
dupix mse peak sale share econom limit earn contribut
blood disord franchis eloct resili competit new launch
sutimlimab data agglutinin diseas
risk achiev price target
cost save
downsid risk stronger diabet sale eros competit ms hemophilia
act financi advisor bristol-my squibb compani
relat agreement celgen corpor celgen inc
would acquir global right otezla apremilast
announc august transact pursuant merger agreement
celgen propos transact subject celgen
enter consent decre feder trade commiss connect
pend merger close pend merger satisfact customari
author materi act capac attorney hold
materi intend either legal opinion legal
advic inform provid herein provid possibl outcom
probabl outcom result legal disput controversi depend
varieti factor includ limit parti histor relationship law
pertain case rel litig talent trial locat juri composit judg
composit investor contact legal advisor issu law relat
subject matter materi
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report matthew
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
www morganstanley com/institutional/research/conflictpolici portugues version polici found www morganstanley com br
import us regulatori disclosur subject compani
juli benefici own class common equiti secur follow compani cover morgan
within last month manag co-manag public offer offer secur alector inc argenx se avrobio inc
within last month receiv compens invest bank servic alector inc argenx se avrobio inc
next month expect receiv intend seek compens invest bank servic akebia
within last month receiv compens product servic invest bank servic amgen inc
within last month provid provid invest bank servic invest bank client relationship
follow compani alder biopharmaceut inc alector inc alnylam
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani amgen inc beigen ltd biogen inc biomarin
 co llc make market secur alder biopharmaceut inc alector inc
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
use rel rate system use term overweight equal-weight not-rat underweight see definit morgan
stanley assign rate buy hold sell stock cover overweight equal-weight not-rat underweight equival
buy hold sell investor care read definit rate use morgan stanley research addit sinc morgan stanley research
contain complet inform concern analyst view investor care read morgan stanley research entireti infer
content rate alon case rate research use reli upon invest advic investor decis buy sell
stock depend individu circumst investor exist hold consider
juli
stock rate describ appli fundament equiti research appli debt research produc firm
disclosur purpos accord nasd nyse requir includ categori head buy hold sell alongsid
rate overweight equal-weight not-rat underweight assign rate buy hold sell stock cover
overweight equal-weight not-rat underweight equival buy hold sell repres recommend rel weight see
definit satisfi regulatori requir correspond overweight posit stock rate buy recommend correspond
equal-weight not-rat hold underweight sell recommend respect
data includ common stock adr current assign rate invest bank client compani receiv invest
bank compens last month due round decim percentag provid total column may add exactli
overweight stock total return expect exceed averag total return analyst industri industri team coverag univers
risk-adjust basi next month
equal-weight stock total return expect line averag total return analyst industri industri team coverag univers
risk-adjust basi next month
not-rat nr current analyst adequ convict stock total return rel averag total return analyst
industri industri team coverag univers risk-adjust basi next month
underweight stock total return expect averag total return analyst industri industri team coverag univers
risk-adjust basi next month
unless otherwis specifi time frame price target includ morgan stanley research month
attract analyst expect perform industri coverag univers next month attract vs relev broad
market benchmark indic
in-lin analyst expect perform industri coverag univers next month line relev broad market
benchmark indic
cautiou analyst view perform industri coverag univers next month caution vs relev broad market
benchmark indic
benchmark region follow north america latin america relev countri index latin america index europ
europ japan topix asia relev countri index sub-region index ac asia pacif ex japan index
stock price price target rate histori rate definit
import disclosur morgan stanley smith barney llc custom
import disclosur regard relationship compani subject morgan stanley research morgan stanley smith barney
llc affili avail wealth manag disclosur websit
www morganstanley com/online/researchdisclosur specif disclosur may refer
morgan stanley equiti research report review approv behalf morgan stanley smith barney llc review approv conduct
person review equiti research report behalf could creat conflict interest
 co plc affili signific financi interest debt secur amgen inc biogen inc celgen corp
morgan stanley research polici updat research report research analyst research manag deem appropri base
develop issuer sector market may materi impact research view opinion state therein addit certain
research public intend updat regular period basi weekly/monthly/quarterly/annu ordinarili updat
frequenc unless research analyst research manag determin differ public schedul appropri base current condit
act municip advisor opinion view contain herein intend constitut advic within
mean section dodd-frank wall street reform consum protect act
produc equiti research product call tactic idea view contain tactic idea particular stock may contrari
recommend view express research stock may result differ time horizon methodolog market event
factor research avail particular stock pleas contact sale repres go matrix http //www morganstanley com/matrix
research provid client proprietari research portal matrix also distribut electron
client certain research product also made avail client third-parti vendor redistribut client
altern electron mean conveni access avail morgan stanley research pleas contact sale repres go matrix
access and/or use research subject term use http //www morganstanley com/term html access
and/or use morgan stanley research indic read agre bound term use
http //www morganstanley com/term html addit consent process person data use cooki accord
privaci polici global cooki polici http //www morganstanley com/privaci pledg html includ purpos set prefer
collect readership data deliv better person servic product find inform morgan
stanley process person data use cooki reject cooki see privaci polici global cooki polici
agre term use and/or wish provid consent process person data use cooki
pleas access research
morgan stanley research provid individu tailor invest advic morgan stanley research prepar without regard
circumst object receiv recommend investor independ evalu particular invest
strategi encourag investor seek advic financi advis appropri invest strategi depend investor
circumst object secur instrument strategi discuss morgan stanley research may suitabl investor
certain investor may elig purchas particip morgan stanley research offer buy sell solicit
offer buy sell security/instru particip particular trade strategi valu incom invest may vari
chang interest rate foreign exchang rate default rate prepay rate securities/instru price market index oper
financi condit compani factor may time limit exercis option right securities/instru
transact past perform necessarili guid futur perform estim futur perform base assumpt may
realiz provid unless otherwis state close price cover page primari exchang subject compani
fix incom research analyst strategist economist princip respons prepar research receiv
compens base upon variou factor includ qualiti accuraci valu research firm profit revenu includ fix incom trade
capit market profit revenu client feedback competit factor fix incom research analyst strategist economist
compens link invest bank capit market transact perform profit revenu particular
import us regulatori disclosur subject compani section research list compani mention
